NDC 00008-1222-01
Pristiq (Desvenlafaxine Succinate)
Package · 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC
100 mg/1 · Extended-Release Tablet
By Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
Desvenlafaxine Succinate · Extended-Release Tablet · 100 mg
- NDC
- 00008-1222-01
- Route
- Oral
- Therapeutic class
- Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor
- Marketing category
- NDA
Request This Medication
*Expect a reply within 2 business hours with availability and pricing.
Additional information
Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.
Request a Quote
Request this medication.
Tell us the quantity you need and we’ll respond with availability, lot details, dating, and pricing within 2 business hours. Mark it as Rush or Emergency if you need it faster.
- DSCSA-compliant pedigree on every order
- Cold-chain capable where applicable
- Same-day fulfillment available for urgent needs
Related in Neurological & Psychiatric
See all →
Guna-Mood
Solution / Drops
NDC 17089-0265-18
1 BOTTLE, DROPPER in 1 BOX (17089-265-18) / 30 mL in 1 BOTTLE, DROPPER
Available to Source
Neuro Links
Liquid
NDC 60564-0003-01
30 mL in 1 BOTTLE, DROPPER
Available to Source
Allergy Rescue
Liquid
NDC 43742-1249
Available to Source
New Stock Fungi Mix
.0000625 g/mL / .0000625 g/mL +14 · Solution
NDC 22840-9650
Available to Source